• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Apitoria Pharma

Apitoria Pharma News

Business

Aurobindo Pharma's Hyderabad API Unit Faces USFDA Inspection with Two Observations

Ryan Peterson 18 Dec, 2024

Aurobindo Pharma reports that the USFDA inspected its subsidiary Apitoria Pharma's API manufacturing facility in Hyderabad with two procedural observations, to be addressed within ...

Popular News

  • Property

    Vietnam's Billionaire Pham Nhat Vuong Launches $1.7B Da Nang Tourism Complex, A New Era of Luxury and Sustainability

    07 Jul, 2025
  • Business

    US Security Panel's Uncertainty Over Nippon Steel's Acquisition of U.S. Steel

    15 Dec, 2024
  • Market

    Asia-Pacific Markets Hold Steady Amid Mixed PMI Reports and Political Developments

    24 Mar, 2025
  • Crypto

    Ripple Labs Makes a Bold Move: Acquires Hidden Road for $1.25 Billion to Strengthen Crypto Market Position

    08 Apr, 2025
  • Market

    Dow Jumps 230 Points in Premarket, Rebounding from Yesterday's Sharp Decline

    05 Mar, 2025
  • Market

    Asia-Pacific Markets Show Mixed Reactions Ahead of Crucial Federal Reserve Interest Rate Decision

    30 Jul, 2025
  • Economy

    Swiss Business Group Alarmed by US Tariffs: Calls for Immediate Government Action

    03 Apr, 2025
  • Crypto

    Bithumb Teams Up with KB Kookmin Bank: A Game-Changer for Crypto Transactions Starting Today

    24 Mar, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.